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IT is well known that rubella infection occurring during the first four months in
pregnancy is associated with a high incidence of congenital abnormalities in the
foetus.' In Northern Ireland it is considered that an average of eight handicapped
infants are born annually as a result of rubella.2 In order to prevent this problem,
routine immunisation of 11 -14 year old girls was introduced in 1971 in Northern
Ireland following a DHSS recommendation.3 However, this programme has not
been entirely effective and vaccination uptake in schoolgirls has fallen from 90 per
cent during the years 1971-73 to 65 per cent during 1975-77. Furthermore, it has
become clear that a substantial proportion of pregnant women who would have
qualified for rubella immunisation as schoolgirls are not immune.
A Department ofHealth and Social Services (DHSS) working party report (1976)
recommended that adult women should be screened for rubella antibody so that
non-immune women could be identified and with certain safeguards offered
immunisation.4 In 1979 the DHSS (N.I.) urged renewed efforts to increase the
uptake of vaccine in all groups. Accordingly a serological screening service was
introduced and this was sited at the Northern Ireland Blood Transfusion Service
which was already receiving blood samples from all ante-natal patients in the
province. It was decided that ante-natal patients should be screened and
immunisation offered to those who were found to be non-immune during the post-
partum period. As the vaccine is a live virus which could, at least theoretically, have
teratogenic effects, it is considered important to ensure that pregnancy is avoided
for at least three months following immunisation.
The policy has obvious disadvantages in that protection can never beprovided for
the pregnancy during which non-immunity is discovered. In addition it was advised
that other groups should be screened, e.g. pre-menopausal blood donors, women
attending family planning and infertility clinics and certain occupational groups at
particular risk of contacting rubella such as nurses and teachers. We wish to report
on three aspects of this programme: (1) the incidence of non-immunity among
women inthechild-bearing agegroup, (2) certain factors influencing immune status,
(3) the success of the programme to date as judged by sero-conversion rates at
follow-up.
POPULATION AND METHODS
It was considered useful to divide the population to be screened into three groups:
ante-natal patients, blood donors and specific requests. Blood samples are received
routinely for other purposes from all ante-natal patients and blood donors and so it
was of interest to consider the success of immunisation in these two groups (95 per
cent of total) for whom no requests for specific rubella screening had been made.
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(S.R.H.) test. This has been an important development which is not only more
reliable than the previously used haemoglutination inhibition test but is also much
less time consuming and therefore suitable for mass screening.5 One slight
disadvantage is its failure to detect IgM antibodies and it is therefore of no value in
the diagnosis of acute infections. It is widely considered at present that
immunisation should be offered to those with antibody levels below 15 iu/ml.
Women with antibody levels below this are reported as either negative or low
immunity (< 15 iu/ml). In the case of ante-natal patients reports are sent to the
ante-natal clinic or general practitioner providing the sample, whereas blood donors
are informed personally by means of an explanatory letter.
It was decided to analyse the correlation, ifany, between immunity to rubella and
recollection of previous infection and recollection of previous immunisation. It was
thought that the results might provide some useful information regarding the
selection of women for screening, e.g. a positive recollection may influence the
patient and possibly their doctor as to the need for immunisation. Accordingly, a
questionaire was conducted among 2,718 female blood donors who qualified for a
screening test (aged under 45 years). These donors were asked questions from a
standard form about their recollection of previous infections or immunisation. The
answers were correlated with the immune status of the subjects concerned.
Files are kept on all individuals requiring immunisation so that it is possible to
monitor the success of the programme as judged by the proportion who have
become immune on follow-up testing, e.g. subsequent pregnancies. The immune
status of blood donors is marked on the donor cards and non-immune women are
re-tested at subsequent donations.
RESULTS
Approximately 45,000 tests per annum have been performed since April 1979 of
which about 80 per cent were ante-natal samples. The incidence of non-immune
subjects has varied little during this period having been approximately 9 per cent
during 1979 (5 per cent negative and 4 per cent low immunity) and has dropped to
7.5 per cent during 1981. The 160 non-immune subjects among the 2,718 female
blood donors were analysed with regard to factors associated with immunity. As
many as 37 (20 per cent) gave a positive history of German measles, whereas 29 per
cent of immune subjects gave a history of German measles. Questioned about
rubella immunisation, 37 of 160 non-immune subjects (23 per cent) had a positive
recollection and 36.5 per cent ofimmune subjects had the same recollection. Similar
data are not available for ante-natal patients.
Many of the women tested during the ante-natal period have now had further
pregnancies and an analysis of a random sample of 128 of these subjects who were
non-immune during a previous pregnancy has shown that only 28 (21 per cent) have
acquired adequate immunity in the interval since their previous pregnancy. Follow-
up data on 1,355 blood donors found to be non-immune showed that 278 (20.5 per
cent) had become immune at the time of subsequent blood donation. It should be
noted that the rubella epidemic of 1980 took place during the follow-up period for
most of the ante-natal patients and blood donors.
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Our data show that during 1979 approximately 9 per cent of women became
pregnant without adequate protection against rubella. This figure has fallen to 7.5
per cent during 1981. This slight reduction may reflect an improvement in
immunisation uptake but the rubella epidemic in 1980 may also have played a part.
These figures are better than most others recorded recently from the United
Kingdom which vary from 8 to 15 per cent.6 7. 8
Our questionaire of blood donors revealed that a substantial proportion of non-
immune subjects gave a history ofGerman measles (23 per cent). This is perhaps not
surprising in view of the notorious difficulty in making a clinical diagnosis of
German measles. Similarly, 23 per cent of non-immune subjects said they recalled
having rubella immunisation. Two factors may explain this discrepancy: (1) an
erroneous history which is understandable in that rubella immunisation could well
have been confused with B.C.G. vaccination and (2) failure of the vaccine to cause
seroconversion or failure ofantibody levels to be maintained. The latter seems a less
likely cause as various studies have shown seroconversion rates of95-99 per cent.8 9
Furthermore duration ofimmunity, although stillunknown, appears to be at least 10
years in the majority of people.'0 These findings strongly indicate that an oral
history from patients of German measles infection or immunisation should be
disregarded when deciding about the need for a screening test, and this is in keeping
with another study.7
So far our follow-up records on ante-natal patients indicate that theproportion of
non-immune women being immunised post partum is extremely disappointing. Only
21.9 per cent of 128 women analysed have shown seroconversion on follow-up and
as the available rubella vaccines have very high seroconversion rates this figure
should approximate to theproportion beingimmunised post-partum. It may even be
an overestimate as some of the seroconversions may have been due to natural
infection. These results agree with another study in the same community which
analysed the rate of post-partum vaccine uptake, (21.5 per cent) in women reported
as non-immune during the ante-natal period."I It is obvious that the present method
of reporting the laboratory results to the clinic or general practitioner providing the
blood sample and explaining the need for immunisation has not been successful.
McConnell"I has investigated methods ofimproving vaccine uptake among the ante-
natal patients in this community and found that one to one education about rubella
during theearly post partum period by ahealth visitor increases vaccine uptake from
21.5 per cent to 66 per cent. Such a policy is under consideration at present. The low
seroconversion rates (20.5 per cent) which we have found in blood donors who were
informed of the need for vaccination in person by means of an explanatory letter
would seem to be slightly at odds with McConnell's findings. However, it should be
remembered that apart from the different methods of communication used, blood
donors differ from ante-natal patients very significantly, particularly with regard to
further child-bearing intentions.
As already stated the ante-natal screening programme in isolation will always fail
to provide protection for the first pregnancy and the best long-term solution to this
problem is to improve vaccine uptake among schoolgirls.
69SUMMARY
Since 1979 in Northern Ireland all ante-natal patients and certain other groups of
females in the child-bearing age group have been screened for immunity to rubella
with a view to offering immunisation to those who are non-immune. During this
period theoverallincidence ofnon-immunityhas fallen from9percent(1979)to7.5
per cent (1981). The results ofaquestionnaire indicatethat a substantial proportion
of non-immune women give a history of rubella infection or immunisation
indicating that such a history should be ignored when deciding about the need for a
screening test. Follow-up studies indicate that the rate of post-partum vaccine
uptake among women tested during the ante-natal period is very poor (approx. 20
per cent). The implications ofthese findings are discussed.
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